Company intelligence / Profile preview

Gencurix

Ownership: Private
Employees: ~69
Development stage: Commercial

Overview

Gencurix develops and commercializes innovative molecular diagnostic solutions, with a focus on precision medicine. Its flagship product, the GenesWell™ system—including the GenesWell BCT multigene test—enables more precise prognostic assessment and personalized treatment planning for early-stage breast cancer patients. The company has also developed COVID‑19 molecular tests that received emergency use authorization in June 2020. Gencurix collaborates with global research institutes and hospitals to advance its clinical pipeline.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Diagnostic testMolecular diagnosticGenetic assayIn vitro diagnostic device (IVD)
Industry: Molecular Diagnostics

Drug pipeline

3 assets

GenesWell BCT

Commercial

Indications: Breast cancer

2 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with global research institutes and hospitals; specific partners not named in available sources.

Beyond the preview

Go deeper on Gencurix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gencurix.

Explore the full profile